Browsing by Contributors Of, Ournal

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 21 to 40 of 275 < previous   more >
PreviewIssue DateTitleContributor(s)
2016 JCO Volume 34 Issue 12 April (22).pdf.jpg2016Chemoradiotherapy in Gastric Cancer : A Door AjarOf, Ournal
2016 JCO Volume 34 Issue 8 March (26).pdf.jpg2016Chemotherapy for Muscle-Invasive Bladder Cancer : Better Late Than Never ?Of, Ournal
2016 JCO Volume 34 Issue 32 November (5).pdf.jpg2016Clinical Utility of Biomarker Tests in Decisions on Extended Endocrine TherapyOf, Ournal
2016 JCO Volume 34 Issue 33 November (31).pdf.jpg2016A Cola to Improve My EGFR TKI Absorption in Metastatic Non – Small-Cell Lung Cancer ? No , Thank You , I Prefer Lemonade or Orange Juice InsteadOf, Ournal
2016 JCO Volume 34 Issue 24 August (25).pdf.jpg2016Comment on the American Society of Clinical Oncology Value StatementOf, Ournal
2016 JCO Volume 34 Issue 5 February (25).pdf.jpg2016Comment on “ Ef fi cacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer : Outcomes From the CONKO-004 Trial ”Of, Ournal
2016 JCO Volume 34 Issue 22 August (22).pdf.jpg2016Comparing Two Multifraction Spine Radiotherapy Regimens : Are They Really Equivalent ?Of, Ournal
2016 JCO Volume 34 Issue 33 November (22).pdf.jpg2016Comprehensive Geriatric Assessment- Guided Therapy Does Improve Outcomes of Older Patients With Advanced Lung CancerOf, Ournal
2016 JCO Volume 34 Issue 3 January (5).pdf.jpg2016Computerized Physician Order Entry – Based System Improves Hepatitis B Virus Screening in Patients Undergoing ChemotherapyOf, Ournal
2016 JCO Volume 34 Issue 16 June (20).pdf.jpg2016The ( Con- ) Fusion in ALK Diagnostics : When Food and Drug Administration – Approved AlgorithmsOf, Ournal
2016 JCO Volume 34 Issue 24 August (24).pdf.jpg2016Coronary Heart Disease After Mediastinal Radiotherapy for Hodgkin Lymphoma : Can Risk Calculations From Historic Cohorts Be Used Today ?Of, Ournal
JCO 2017 Volume 35 Issue 4 February (11).pdf.jpg2017Covariate-Adjusted Restricted Mean Survival Times and CurvesOf, Ournal
2016 JCO Volume 34 Issue 24 August (2).pdf.jpg2016Critique of the American Society of Clinical Oncology Value Assessment Framework for Cancer Treatments : Putting Methodologic Robustness FirstOf, Ournal
2016 JP Volume 176 September (53).pdf.jpg2016CURRENT BEST EVIDENCE Translating Best Evidence into Best CareOf, Ournal
2016 JCO Volume 34 Issue 16 June (2).pdf.jpg2016Current Status of Supplemental Screening in Dense BreastsOf, Ournal
2016 JCO Volume 34 Issue 28 October (12).pdf.jpg2016Dangers of Excluding Margin Status From a Ductal Carcinoma In Situ Prognostic ScoreOf, Ournal
JCO 2017 Volume 35 Issue 7 March (19).pdf.jpg2017Debated Role of Ovarian Protection With Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Women With CancerOf, Ournal
2016 JCO Volume 34 Issue 16 June (28).pdf.jpg2016Definition of First-Line Endocrine Therapy for Hormone Receptor – Positive Advanced Breast CancerOf, Ournal
2016 JCO Volume 34 Issue 30 October (18).pdf.jpg2016Demystifying the Association of Chemotherapy and Cognition : How Close Are We ?Of, Ournal
2017 DAD Volume 171 February (122).pdf.jpg2017Distinguishing Among Pediatric Hepatoblastomas , Transitional Liver Cell Tumors , and Hepatocellular Carcinomas and Using Appropriate Chemotherapy RegimensOf, Ournal